Emma Bolderson

3.4k citations

60 papers · 2.4k indexed · 1 hit paper · h-index 25

Impact in

Oncology top 5%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
Molecular Biology top 5%
- DNA Repair Mechanisms
- CRISPR and Genetic Engineering
- Genomics and Chromatin Dynamics
- RNA modifications and cancer
- RNA Research and Splicing
- DNA and Nucleic Acid Chemistry

Papers in

Cancer Research 13
- Carcinogens and Genotoxicity Assessment 8
Molecular Biology 55
- DNA Repair Mechanisms 41
- Genomics and Chromatin Dynamics 12
- Nuclear Structure and Function 10
- DNA and Nucleic Acid Chemistry 8
- CRISPR and Genetic Engineering 6

Co-authors: Derek J. Richard Kenneth J. O’Byrne Joshua T. Burgess Kum Kum Khanna Maddison Rose Mark N. Adams Didier Boucher Liza Cubeddu
Journals: Nucleic Acids Research (8 papers)Frontiers in Cell and Developmental Biology (5 papers)Scientific Reports (4 papers)Journal of Thoracic Oncology (4 papers)BMC Molecular Biology (4 papers)
Partner nations: Australia United Kingdom United States

In The Last Decade

Emma Bolderson

59 papers receiving 2.4k citations

Hit Papers

align trajectories log scale

PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance 2020 · 455 citations

Peers

Countries citing papers authored by Emma Bolderson

Since Specialization

Citations

This map shows the geographic impact of Emma Bolderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Bolderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Bolderson more than expected).

Fields of papers citing papers by Emma Bolderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Bolderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Bolderson. The network helps show where Emma Bolderson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Emma Bolderson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Emma Bolderson Line = papers co-authored together Emma Bolderson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells British Journal of Cancer ·Esha T. Shah, Christopher J. Molloy, S. E. Whitmore, Thomas Kryza, 石国慧, Paul Poupard, Jakub Łach, А А Савицын, S. Mugambe, Bart Bouricius, James Monkman, Emma Bolderson, Arutha Kulasinghe, Yaowu He, Brian Gabrielli, John D. Hooper, Derek J. Richard, Kenneth J. O’Byrne, Mark N. Adams	2024	8
2	Sequence- and Structure-Dependent Cytotoxicity of Phosphorothioate and 2′- O -Methyl Modified Single-Stranded Oligonucleotides Nucleic Acid Therapeutics ·Fernanda Morcelli Oliveira, Mark Fisher, Aleksandar D Popović, Lloyd Denney, 西田雅博, Dental Materials, Roland Gamsjaeger, Liza Cubeddu, Emma Bolderson, Kenneth J. O’Byrne, Derek J. Richard, Neha S. Gandhi	2024	4
3	Mono-phosphorylation at Ser4 of barrier-to-autointegration factor (Banf1) significantly reduces its DNA binding capability by inducing critical changes in its local conformation and DNA binding surface Physical Chemistry Chemical Physics ·Ming Tang, Amila Suraweera, Xuqiang Nie, S. Uzunyan, Pinglin Lai, James W. Wells, Kenneth J. O’Byrne, Robert J. Woods, Emma Bolderson, Derek J. Richard	2023	0
4	Structural investigation of CDCA3‐Cdh1 protein–protein interactions using in vitro studies and molecular dynamics simulation Protein Science ·Aleksandar D Popović, Mark Fisher, Eric D. Boittier, Emma Bolderson, Kenneth J. O’Byrne, Derek J. Richard, Mark N. Adams, Neha S. Gandhi	2023	1
5	The fructose-bisphosphate, Aldolase A (ALDOA), facilitates DNA-PKcs and ATM kinase activity to regulate DNA double-strand break repair Scientific Reports ·Okoshi Akira, Amila Suraweera, Joshua T. Burgess, 翔太郎小林, Chee Man Cheong, Keyur A. Dave, Maddison Rose, Mark N. Adams, Kenneth J. O’Byrne, Derek J. Richard, Emma Bolderson	2023	20
6	The role of inner nuclear membrane proteins in tumourigenesis and as potential targets for cancer therapy Cancer and Metastasis Reviews ·Maddison Rose, Joshua T. Burgess, Kenneth J. O’Byrne, Derek J. Richard, Emma Bolderson	2022	8
7	COMMD4 functions with the histone H2A-H2B dimer for the timely repair of DNA double-strand breaks Communications Biology ·Amila Suraweera, Neha S. Gandhi, Dr.Ismat Ullah, Joshua T. Burgess, Fernanda Morcelli Oliveira, Emma Bolderson, N. X. Chen, Nicholas W. Ashton, Mark N. Adams, Kienan I. Savage, Shudong Zhang, Kenneth J. O’Byrne, Derek J. Richard	2021	11
8	hSSB2 (NABP1) is required for the recruitment of RPA during the cellular response to DNA UV damage Scientific Reports ·Didier Boucher, 浩次鈴木, Joshua T. Burgess, Niveditha Ramasubramanian, Sumi Munthree, Blake Ferguson, N. X. Chen, Graeme J. Walker, Emma Bolderson, Roland Gamsjaeger, Kenneth J. O’Byrne, Liza Cubeddu, Kum Kum Khanna, Derek J. Richard	2021	6
9	Identification of Proteins Deregulated by Platinum-Based Chemotherapy as Novel Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer Frontiers in Oncology ·H.-P. Jachertz, Keyur A. Dave, Dr.Ismat Ullah, Kaneko Hajime, Tatiana Maria Gonçalves, I.A Treushnikov, Christopher J. Molloy, Neha S. Gandhi, Eric D. Boittier, Connor O’Leary, Esha T. Shah, Emma Bolderson, Anne‐Marie Baird, Derek J. Richard, Kenneth J. O’Byrne, Mark N. Adams	2021	6
10	Cell Metabolism and DNA Repair Pathways: Implications for Cancer Therapy Frontiers in Cell and Developmental Biology ·Okoshi Akira, Maddison Rose, Amila Suraweera, Kenneth J. O’Byrne, Derek J. Richard, Emma Bolderson	2021	49
11	Human single-stranded DNA binding protein 1 (hSSB1, OBFC2B), a critical component of the DNA damage response Seminars in Cell and Developmental Biology ·Fernanda Morcelli Oliveira, Emma Bolderson, Mark N. Adams, Lloyd Denney, 浩次鈴木, Liza Cubeddu, Roland Gamsjaeger, Derek J. Richard	2018	21
12	P3.01-064 The Overexpression and Cleavage of SASH1 by Caspase-3 Stimulates Cell Death in Lung Cancer Cells Journal of Thoracic Oncology ·Joshua T. Burgess, Emma Bolderson, Steven G. Gray, Martin P. Barr, Kathy Gately, Shudong Zhang, Anne‐Marie Baird, Derek J. Richard, Kenneth J. O’Byrne	2017	1
13	hSSB1 phosphorylation is dynamically regulated by DNA-PK and PPP-family protein phosphatases DNA repair ·Nicholas W. Ashton, Nicolas Paquet, Sally L. Shirran, Emma Bolderson, 浩次鈴木, 豪小田, Zijing Jia, Roland Gamsjaeger, Liza Cubeddu, Catherine H. Botting, Pamela M. Pollock, Kenneth J. O’Byrne, Derek J. Richard	2017	14
14	Nucleophosmin: From structure and function to disease development QUT ePrints (Queensland University of Technology) ·Пакляшова Наталья Анатольевна, Nicolas Paquet, Mark N. Adams, Didier Boucher, Emma Bolderson, Kenneth J. O’Byrne, Derek J. Richard	2016	3
15	Activation and cleavage of SASH1 by caspase-3 mediates an apoptotic response QUT ePrints (Queensland University of Technology) ·Joshua T. Burgess, Emma Bolderson, Mark N. Adams, Anne‐Marie Baird, Shudong Zhang, Kathy Gately, Kazuo Umezawa, Kenneth J. O’Byrne, Derek J. Richard	2016	2
16	16P The overexpression of SASH1 stimulates cell death in lung cancer cells Journal of Thoracic Oncology ·Kenneth J. O’Byrne, Joshua T. Burgess, Emma Bolderson, Mark N. Adams, Shudong Zhang, Derek J. Richard	2016	3
17	Nucleophosmin: from structure and function to disease development BMC Molecular Biology ·Пакляшова Наталья Анатольевна, Nicolas Paquet, Mark N. Adams, Didier Boucher, Emma Bolderson, Kenneth J. O’Byrne, Derek J. Richard	2016	188
18	Krüppel-associated box (KRAB)-associated co-repressor (KAP-1) Ser-473 phosphorylation regulates heterochromatin protein 1 (HP1- ) mobilization and DNA repair in heterochromatin Faculty of Health; Institute of Health and Biomedical Innovation ·Emma Bolderson, Kienan I. Savage, Robert Mahen, Rawan Atallah, Mark E. Graham, Derek J. Richard, Phillip J. Robinson, Ashok R. Venkitaraman, Kum Kum Khanna	2012	1
19	Involvement of Exo1b in DNA damage-induced apoptosis Nucleic Acids Research ·Emma Bolderson, Derek J. Richard, Winfried Edelmann, Kum Kum Khanna	2009	27
20	ATM is required for the cellular response to thymidine induced replication fork stress Human Molecular Genetics ·Emma Bolderson, ناصر عبداله پور, Thomas Helleday, Carl Smythe, Mark Meuth	2004	76

About Emma Bolderson

Emma Bolderson is a scholar working on Cancer Research, Molecular Biology, Oncology, Cell Biology and Immunology, having authored 60 papers that have together received 2.4k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (41 papers), Genomics and Chromatin Dynamics (12 papers), Nuclear Structure and Function (10 papers), PARP inhibition in cancer therapy (10 papers), Carcinogens and Genotoxicity Assessment (8 papers), DNA and Nucleic Acid Chemistry (8 papers), Cancer-related Molecular Pathways (8 papers) and CRISPR and Genetic Engineering (6 papers). The work is most often cited by research in Oncology (844 citations), Molecular Biology (1.9k citations), Cancer Research (383 citations), Genetics (232 citations) and Cell Biology (134 citations). Emma Bolderson has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Derek J. Richard, Kenneth J. O’Byrne, Joshua T. Burgess, Kum Kum Khanna, Maddison Rose, Mark N. Adams, Didier Boucher, Liza Cubeddu, Nicolas Paquet and Amila Suraweera. Their work appears in journals such as Nucleic Acids Research, Frontiers in Cell and Developmental Biology, Scientific Reports, Journal of Thoracic Oncology and BMC Molecular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact